Send Message
products

Chemical Pharmaceutical Preparation Benfotiamine Powder CAS 22457-89-2

Basic Information
Place of Origin: China
Brand Name: HNB
Certification: ISO
Model Number: Benfotiamine
Minimum Order Quantity: 1KG
Price: Negotiable
Packaging Details: Aluminum foil bag
Delivery Time: Usually7-10days
Payment Terms: L/C, D/A, D/P, T/T, , MoneyGram
Supply Ability: 5000kg/Month
Detail Information
CAS: 22457-89-2 Mf: C19H23N4O6PS
Specification: ≥99% Appearance: White Crystalline Powder
Molecular Weight: 466.4479 EINECS No.: 245-013-4
Solubility: Insoluble In Water
High Light:

Pharmaceutical Grade Benfotiamine Powder

,

Chemical Pharmaceutical Preparation Benfotiamine Powder

,

API Pharmaceutical 22457-89-2


Product Description

Chemical Pharmaceutical Preparation CAS 22457-89-2 Benfotiamine Powder

 

Production name  Benfotiamine
MOQ 1KG
CAS No. 22457-89-2
Appearance White Crystalline Powder
Molecular Formula C19H23N4O6PS
Molecular Weight 466.4479
Grade Pharmaceutical Grade
EINECS No. 245-013-4
Assay 99%

 

Chemical Pharmaceutical Preparation Benfotiamine Powder CAS 22457-89-2 0
 

 

The Introductction of Benfotiamine :

 

Benfotiamine is vitamin B1 fat soluble derivatives, improve the bioavailability of water-soluble vitamin B1 low shortcomings, improve the blood and tissue concentrations of thiamine, so as to improve the curative effect
Benfotiamine is primarily marketed as an antioxidant dietary supplement. In a clinical study with six patients, benfotiamine lowered AGE by 40%.


Benfotiamine is useful for the treatment of diabetic retinopathy, neuropathy, and nephropathy however "Most of the effects attributed to benfotiamine are extrapolated from in vitro and animal studies. Unfortunately apparent evidences from human studies are scarce and especially endpoint studies are missing. Therefore additional clinical studies are mandatory to explore the therapeutic potential of benfotiamine in both diabetic and non-diabetic pathological conditions".
It is thought that treatment with benfotiamine leads to increased intracellularthiamine diphosphate levels, a cofactor of transketolase. This enzyme directs advanced glycation and lipoxidation end products (AGE's, ALE's) substrates to the pentose phosphate pathway, thus reducing tissue AGEs.

 

The Application & Function of Benfotiamine :

 

Function

A.Iis used for the prevention and treatment of vitamin B1 deficiency;
B. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
C. Is used in the treatment of non alcoholic wernicke encephalopathy;
D. To treat beriberi;
E. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.

Application

1. Benfotiamine is used for the prevention and treatment of vitamin B1 deficiency;
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
3. Benfotiamine is used in the treatment of non alcoholic wernicke encephalopathy;
4. To treat beriberi;
5. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.

 

Chemical Pharmaceutical Preparation Benfotiamine Powder CAS 22457-89-2 1Chemical Pharmaceutical Preparation Benfotiamine Powder CAS 22457-89-2 2Chemical Pharmaceutical Preparation Benfotiamine Powder CAS 22457-89-2 3

Contact Details
Haylee Wang

Phone Number : +8615399065181

WhatsApp : +8618629242069